Article Data

  • Views 1365
  • Dowloads 148

Meeting Abstracts

Open Access Special Issue

Genetics-guided treatment for chronic pain

  • Efklidis Raptis1

1Medical Effectiveness & Obesity, South & East Europe, Middle East, Novo Nordisk, Africa

DOI: 10.22514/sv.2021.199 Vol.17,Issue S1,September 2021 pp.56-56

Submitted: 26 August 2021 Accepted: 06 September 2021

Published: 15 September 2021

*Corresponding Author(s): Efklidis Raptis E-mail:


Chronic pain treatment is often compromised by adverse reactions, low efficacy, and potentially dangerous drug interactions. Genetics may, in some cases, help avoid such issues and it is conceivable that, in the near future, the treatment of chronic pain will be guided -at least in part- by the genetic background of individual patients. A typical example is the polymorphisms of the cytochrome enzymes (e.g., P450); understanding their impact on substrate metabolism can significantly help to avoid lack of efficacy and adverse events for medications often used in the treatment of chronic pain, such as opioids, NSAIDs and membrane stabilizers (antiepileptics). There is abundant literature on other relevant examples, such as receptors polymorphisms (e.g., OPRM1), HLA genotypes (e.g., HLA-A*31:01), enzyme and transporter polymorphisms (e.g., COMT, UGT, ABCB1), cytokine profiles (π.χ. IL-6), ion channel and transcriptional factor polymorphisms etc. Current research, using data from channelopathies and ion channel mutations related to pain transduction and conduction, attempts to develop treatments for chronic pain syndromes which will utilize a guided and individualized approach to achieve safer and more efficacious therapies. Accordingly, genetics has allowed for the identification of novel modes of action for old compounds already used for the treatment of chronic pain. By combining pharmacogenetics, proteomics, epigenetics and neurophysiology, it is foreseeable that we will manage to approach the underlying pathophysiology of chronic pain in an individualized manner and, consequently, to adapt the treatment. In addition, genetic therapy (e.g., RNAi, ASOs, CRISPRi-KRAB) may further help manage difficult chronic pain syndromes. There are still many barriers to overcome, such as the availability of genetical analytics and their performance, the cost-effectiveness ratio, the lack of relevant data from randomized controlled clinical trials, as well as the limited number of approved treatments with different modes of action for chronic pain.

Cite and Share

Efklidis Raptis. Genetics-guided treatment for chronic pain. Signa Vitae. 2021. 17(S1);56-56.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time